Related Experiment Video

Updated: Aug 29, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Signaling through JAK2-STAT5 pathway is essential for IL-3-induced activation of microglia

Chandramohan Natarajan1, Subramaniam Sriram, Gladson Muthian

  • 1Department of Neurology and Pharmacology, Vanderbilt University Medical Center, 1222F VSRH, 2201 Capers Avenue, Nashville, TN 37212, USA. john.bright@vanderbilt.edu

Glia
|January 20, 2004
PubMed

Insights

Interleukin-3 (IL-3) activates brain microglia via the JAK2-STAT5 pathway. Blocking this pathway reduces microglial activation, proliferation, and expression of key immune molecules, offering therapeutic insights for CNS diseases.

Area of Science:

  • Neuroimmunology
  • Cellular Signaling

Background:

  • Microglia are key immune cells in the central nervous system (CNS).
  • Microglial activation is implicated in neurodegenerative diseases like Alzheimer's and Parkinson's.
  • Interleukin-3 (IL-3) is a cytokine known to activate microglial cells.

Purpose of the Study:

  • To investigate the role of the JAK2-STAT5 signaling pathway in IL-3-induced microglial activation.
  • To determine the downstream effects of blocking this pathway on microglial function.

Main Methods:

  • In vitro treatment of EOC-20 microglial cells with tyrphostin AG490 (a JAK2 inhibitor).
  • Stable transfection of microglial cells with a dominant-negative JAK2 mutant.
  • Assessment of tyrosine phosphorylation of JAK2, STAT5A, and STAT5B.
  • Analysis of IL-3-induced microglial proliferation and expression of CD40 and MHC class II molecules.

Main Results:

  • Tyrphostin AG490 and dominant-negative JAK2 mutant blocked IL-3-induced tyrosine phosphorylation of JAK2, STAT5A, and STAT5B.
  • Inhibition of the JAK2-STAT5 pathway decreased IL-3-induced microglial proliferation.
  • Blockade of this pathway reduced the expression of CD40 and MHC class II molecules in microglia.

Conclusions:

  • The JAK2-STAT5 signaling pathway is essential for IL-3-mediated microglial activation.
  • Targeting the JAK2-STAT5 pathway may offer a strategy for modulating microglial responses in CNS disorders.

More Related Videos

Time-resolved Förster Resonance Energy Transfer Assays for Measurement of Endogenous Phosphorylated STAT Proteins in Human Cells07:12

Time-resolved Förster Resonance Energy Transfer Assays for Measurement of Endogenous Phosphorylated STAT Proteins in Human Cells

Published on: September 9, 2021

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...